Drug’s permission renewal to be made compulsory

The state-run drug regulator plans to complete the approval process determining the terms of the drug’s permission renewal, which will come five years after being put to market.

Under the recently revised bill, the Korea Food and Drug Administration will announce a detailed regulation of the drug’s permission renewal on newly approved drugs, including application procedures and scope of dat...